These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 8976763)
1. Genomic heterogeneity in bladder cancer as detected by fluorescence in situ hybridization. Yokogi H; Wada Y; Moriyama-Gonda N; Igawa M; Ishibe T Br J Urol; 1996 Nov; 78(5):699-703. PubMed ID: 8976763 [TBL] [Abstract][Full Text] [Related]
2. Aneusomy of chromosomes 7 and 17 predicts the recurrence of transitional cell carcinoma of the urinary bladder. Watters AD; Ballantyne SA; Going JJ; Grigor KM; Bartlett JM BJU Int; 2000 Jan; 85(1):42-7. PubMed ID: 10619944 [TBL] [Abstract][Full Text] [Related]
3. Interphase cytogenetics of bladder cancer progression: relationship between aneusomy, DNA ploidy pattern, histopathology, and clinical outcome. Cianciulli AM; Bovani R; Leonardo F; Antenucci A; Gandolfo GM; Giannarelli D; Leonardo C; Iori F; Laurenti C Int J Clin Lab Res; 2000; 30(1):5-11. PubMed ID: 10984125 [TBL] [Abstract][Full Text] [Related]
4. Is chromosome 9 loss a marker of disease recurrence in transitional cell carcinoma of the urinary bladder? Bartlett JM; Watters AD; Ballantyne SA; Going JJ; Grigor KM; Cooke TG Br J Cancer; 1998 Jun; 77(12):2193-8. PubMed ID: 9649132 [TBL] [Abstract][Full Text] [Related]
5. [Detection of urothelial carcinoma of the urinary bladder by multicolor fluorescence in situ hybridization]. Zhang YG; Bi XG; Han YL; Cai Y; Xu X; Wu YP; Yang YL; Ma JH; Zhao P; Jia XM; Wang MR Ai Zheng; 2007 Feb; 26(2):189-93. PubMed ID: 17298751 [TBL] [Abstract][Full Text] [Related]
6. Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer. Waldman FM; Carroll PR; Kerschmann R; Cohen MB; Field FG; Mayall BH Cancer Res; 1991 Jul; 51(14):3807-13. PubMed ID: 1676611 [TBL] [Abstract][Full Text] [Related]
7. Numerical chromosome aberrations in bladder cancer detected by in situ hybridization. Nemoto R; Nakamura I; Uchida K; Harada M Br J Urol; 1995 Apr; 75(4):470-6. PubMed ID: 7788258 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of chromosome 8 and 11 aneuploidies in washings and biopsy materials of bladder transitional cell carcinoma. Acar H; Kilinç M; Yildirim MS; Kaynak M; Cenker A Cancer Genet Cytogenet; 2003 Apr; 142(1):25-9. PubMed ID: 12660029 [TBL] [Abstract][Full Text] [Related]
9. Chromosome 9 aberrations by fluorescence in situ hybridisation in bladder transitional cell carcinoma. Eleuteri P; Grollino MG; Pomponi D; De Vita R Eur J Cancer; 2001 Aug; 37(12):1496-503. PubMed ID: 11506956 [TBL] [Abstract][Full Text] [Related]
10. Chromosomal aberrations in transitional cell carcinoma: its correlation with tumor behavior. Yu DS; Chen HI; Chang SY Urol Int; 2002; 69(2):129-35. PubMed ID: 12187044 [TBL] [Abstract][Full Text] [Related]
11. [Molecular cytogenetic study of bladder transitional cell carcinoma by FISH]. Shou J; Wang M; Ma J Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):36-8. PubMed ID: 11776593 [TBL] [Abstract][Full Text] [Related]
12. DNA aberrations in urinary bladder cancer detected by flow cytometry and FISH. Sauter G; Gasser TC; Moch H; Richter J; Jiang F; Albrecht R; Novotny H; Wagner U; Bubendorf L; Mihatsch MJ Urol Res; 1997; 25 Suppl 1():S37-43. PubMed ID: 9079755 [TBL] [Abstract][Full Text] [Related]
13. Bladder irrigation specimens assayed by fluorescence in situ hybridization to interphase nuclei. Wheeless LL; Reeder JE; Han R; O'Connell MJ; Frank IN; Cockett AT; Hopman AH Cytometry; 1994 Dec; 17(4):319-26. PubMed ID: 7875039 [TBL] [Abstract][Full Text] [Related]
14. Chromosomal aberrations in transitional cell carcinoma that are predictive of disease outcome are independent of polyploidy. Bartlett JM; Adie L; Watters AD; Going JJ; Grigor KM BJU Int; 1999 Nov; 84(7):775-9. PubMed ID: 10532970 [TBL] [Abstract][Full Text] [Related]
16. Numerical chromosome 1, 7, 9, and 11 aberrations in bladder cancer detected by in situ hybridization. Hopman AH; Moesker O; Smeets AW; Pauwels RP; Vooijs GP; Ramaekers FC Cancer Res; 1991 Jan; 51(2):644-51. PubMed ID: 1985781 [TBL] [Abstract][Full Text] [Related]
17. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder. Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510 [TBL] [Abstract][Full Text] [Related]
18. Detection of genetic aberrations in bladder cancer using in situ hybridization. Ramaekers FC; Hopman AH Ann N Y Acad Sci; 1993 Mar; 677():199-213. PubMed ID: 8098592 [No Abstract] [Full Text] [Related]
19. Aneusomy for detection of bladder cancer recurrence: a Southwest Oncology Group study. Wolman SR; Goldman B; Slovak ML; Tangen C; Persons DL; Wood D Cancer Genet Cytogenet; 2007 Jul; 176(1):22-7. PubMed ID: 17574960 [TBL] [Abstract][Full Text] [Related]
20. Nonrandom numerical aberrations of chromosomes 7, 9, and 10 in DNA-diploid bladder cancer. Matsuyama H; Bergerheim US; Nilsson I; Pan Y; Skoog L; Tribukait B; Ekman P Cancer Genet Cytogenet; 1994 Oct; 77(2):118-24. PubMed ID: 7954321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]